Novel monoclonal antibody-based therapies for multiple myeloma
At the 20th Congress of the European Hematology Association (EHA), Sagar Lonial, MD, of the Winship Cancer Institute, Emory University, Atlanta, GA, ...
EMG-Health
Application of Monoclonal Antibodies in Tumor Pathology Developments in Oncology
Alexis Panton
Webinar - Rabbit Monoclonal Antibodies in Tissue Diagnostics
This webinar covers advantages of rabbit monoclonal antibodies (mAbs) in general and their specific application in tissue diagnostics.
GenScript USA Inc.
How are monoclonal antibodies changing the treatment paradigm for myeloma?
At the 20th Congress of the European Hematology Association (EHA), Prof Sagar Lonial, Professor and Executive Vice Chair in the Department of Hematology ...
Patient Power Europe
Antibody Manufacturing Documentary
This documentary on Antibody Manufacturing, produced by Biocompare, captures the perspectives of several manufacturers, including BioLegend, about what ...
BioLegend
Herceptin - the first monoclonal treatment for cancer
This presentation outlines the research and development that led to Herceptin, the first effective monoclonal antibody treatment for cancer. A power-point version ...
Understanding Animal Research
Benefits of recombinant antibody technology for flow cytometry
Let Cap'n T Cell take you on a ride through the wonderful world of REAfinity™ Recombinant Antibodies. In this video, he will explain the benefits of using ...
Miltenyi Biotec
ELCC 2010: The use of monoclonal antibodies to treat mesothelioma
Prof Jan van Meerbeeck, discuses his research into the use of monoclonal antibodies to treat mesothelioma, a disease generally seen in professionally exposed ...
ecancer
The Intravenous Administration of Monoclonal Antibodies
Key opinion leaders provide an overview of various uses of daratumumab in multiple myeloma, and discuss real-world experience administering the treatment ...
OncLiveTV
What are Antibody-drug Conjugates (ADCs)?
Antibody-drug conjugates or ADCs represent an innovative therapeutic application that combines the unique properties of monoclonal antibodies (mAbs) with ...
ADC Review / Journal of Antibody-drug Conjugates
Advances in esophageal cancer: Current and future strategies
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Barbara A. Burtness discusses current and future strategies for esophageal ...
ImedexCME
MD vs. Machine: Artificial intelligence in health care
Recent advances in artificial intelligence and machine learning are changing the way doctors practice medicine. Can medical data actually improve health care?
Harvard Medical School
ASCO's Cancer Advance of the Year, FDA Approval in NETs, and More
Gina Columbus reports on ASCO announces its 2018 Cancer Advance of the Year, an FDA approval in neuroendocrine tumors, a European regulatory upate in ...
OncLiveTV
Current therapy for CLL and the new monoclonal antibody ofatumumab
Tadeusz Robak, MD, PhD from the Medical University of Lodz, Lodz, Poland, discusses his involvement in the development of the fully human monoclonal ...
VJHemOnc – Video Journal of Hematological Oncology
New monoclonal antibodies for ALL treatment
At the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain, Arnon Nagler, MD, from Sheba ...
VJHemOnc – Video Journal of Hematological Oncology
Emerging monoclonal antibodies for lymphoma therapy
At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Thomas J. Kipps, MD, PhD, of the University of California, San Diego, San ...
VJHemOnc – Video Journal of Hematological Oncology
Why are recombinant antibodies important?
Researchers and opinion leaders have considered a number of potential solutions to the so-called antibody-related reproducibility crisis. One is to transition ...
Miltenyi Biotec
Recombinant antibodies in flow cytometry – A transplant immunologist shares his opinion
We asked Dr. James Hutchinson, transplant immunologist at the University Hospital in Regensburg, Germany, what he thinks about recombinant antibodies in ...
Miltenyi Biotec
MCRT Phoenix 2017: Monoclonal Antibodies and Immunotherapies by Leif Bergsagel, MD
Dr Leif Bergsagel, MD of The Mayo Clinic speaks about monoclonal antibodies and immunotherapies in the treatment of multiple myleoma. [FIXED AUDIO] Find ...
Myeloma Crowd TV
Advances in Cancer Immunotherapy - Robert J. Canter, M.D.
Department of Surgery Grand Rounds, 05/31/16 Speaker: Robert J. Canter Cancer, Gastrointestinal Surgery, Surgical Oncology, Sarcoma Department of ...
UC Davis Department of Surgery
ESMO Immuno-Oncology Symposium: from vaccines to antibodies and cell therapies
Immunotherapy at the forefront of cancer therapies: there is an urgent need for medical oncologists to get educated on the basics, the available therapies, their ...
European Society for Medical Oncology
Combination therapies in cancer treatment – Video abstract [ID 61292]
Video abstract of a review paper “Enhancement of antibody-dependent cell mediated cytotoxicity: a new era in cancer treatment” published in the open access ...
Dove Medical Press
When will the first monoclonal antibody be approved?
In this episode of #AskDrDurie, IMF Chairman Dr. Brian Durie discusses the progress being made with monoclonal antibodies being used to treat myeloma.
International Myeloma Foundation
FDA Approvals for Daratumumab and Osimertinib, Regulatory Advances in RCC and CLL, and More
Laura Jones reports on FDA approvals for daratumumab in multiple myeloma and osimertinib for EGFR T790M-mutant non–small cell lung cancer. Plus ...
OncLiveTV
Monoclonal Antibodies for the Treatment of Patients With Multiple Myeloma
Ravi Vij, MD, associate professor of medicine, Division of Oncology, Section of Bone Marrow Transplant, Washington University School of Medicine, discusses ...
Targeted Oncology
Immunotherapy: How the Immune System Fights Cancer
Immunotherapy uses the body's immune system to fight cancer. This animation explains three types of immunotherapy used to treat cancer: nonspecific immune ...
National Cancer Institute
The importance of anti-CD38 monoclonal antibodies for multiple myeloma
Rafael Fonseca, MD from the Mayo Clinic, Scottsdale, AZ discusses the importance of monoclonal antibodies for multiple myeloma (MM). At the American ...
VJHemOnc – Video Journal of Hematological Oncology
R&D Systems Custom Antibody Generation Services - Bio-Techne
R&D Systems manufactures thousands of primary antibodies with high specificity. Learn More About Custom Antibody Production from R&D Systems: ...
R&D Systems, a Bio-Techne brand
Anti-CD38 monoclonal antibodies – a new drug class for treating myeloma
At the Myeloma 2015 meeting held in Boston, Massachusetts, Dr Joseph Mikhael (Mayo Clinic, Scottsdale, AZ) talks about the new class of drugs, the anti-CD38 ...
Patient Power Europe
Recombinant antibodies – Reproducibility crisis
Flow cytometry is in their genes. Discover how REAfinity™ Antibodies are recombinantly engineered to provide superior lot-to-lot consistency and purity ...
Miltenyi Biotec
The Use of Antibodies to Treat Autoimmune Disease - Dr. Alan Lazarus
In this presentation high school students will first be introduced to the immune system. We will discuss how the immune system is organized and how it functions ...
St. Michael's Hospital
Developing a More Efficient MAb Discovery Process
Historically it has taken the industry 20-30 months from the start of the monoclonal antibody (mAb) discovery process to final selection of lead drug candidates.
WuXi Biologics
Are All Chimeric Antigen Receptors Created Equal?
Understanding the Pathway article: http://ascopubs.org/doi/full/10.1200/JCO.2014.57.5472 The Journal of Clinical Oncology's "Understanding the Pathway" ...
ASCOcancer
Monoclonal Antibodies in Squamous Cell Lung Cancer
The panelists, Benjamin Levy, MD; Paul K. Paik, MD; and Edward S. Kim, MD, FACP, highlight monoclonal antibody agents recently approved for the ...
OncLiveTV
Recombinant antibodies in flow cytometry – An expert in immunity and aging shares his opinion
We asked Dr. Anis Larbi, Head of Flow Cytometry Platform at the A*STAR Institute in Singapore and Senior Principal Investigator for Immunity and Aging, what ...
Miltenyi Biotec
Medicine Grand Rounds: Colorectal Cancer 5/15/18
Colorectal Cancer Speaker: Christina Wu, MD Associate Professor Department of Hematology and Medical Oncology Emory University School of Medicine.
Emory Department of Medicine
Immunotherapy/Checkpoint Inhibitor, Targeted Immunotherapy Drugs 5/2/18
MGMC Physician Grand Rounds, 5/2/18 Joseph Merchant, MD, Hematology/Oncology McFarland Clinic.
Mary Greeley Medical Center
10/17/2018 Bispecific Single-Domain Antibody fused to Monoclonal Antibody (SMAB): The Natural Form
In this webinar, we will cover: 1. An overview of therapeutic antibodies, focusing on the opportunities and challenges of current monotherapy. 2. The major ...
GenScript USA Inc.
Advances in SLE and Vasculitis
This webcast discusses SLE pathogenesis, as well as interim results with newer agents in SLE clinical trials. Visit http://www.ccfcme.org/biologicsvideos to claim ...
ClevelandClinicCME
Immunotherapy for Blood Cancers: Updates from the Field, with Hearn Jay Cho, M.D., Ph.D.
Clinical research around the world is focused on helping patients with blood cancers like leukemia, lymphoma, and multiple myeloma to benefit from a new class ...
Cancer Research Institute
Human monoclonal antibodies as therapeutics against viral and bacterial infections
Harnessing nature's gift: human monoclonal antibodies as therapeutics against viral and bacterial infections Air date: Wednesday, April 27, 2016, 3:00:00 PM ...
NIH VideoCast
AACR/ASCO Methods in Clinical Cancer Research Workshop
Patricia M. LoRusso, DO, of the Yale Cancer Center, discusses this workshop on the essentials of effective clinical trial designs of therapeutic interventions in ...
American Association for Cancer Research
